AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Nexien BioPharma, Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0.01
Market Cap
7.08K
AVG Volume
332
Trailing/Forward PE
-0.03/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Net Income (USD)
-25B025B50B75B100B201620172018201920202021202220232024
NXEN Net Income (USD) by year
PeriodNet Income (USD)
2024-239.11K
202382.25B
2022-626K
2021-1.86M
2020-2.67M
2019-4.3M
2018-1.28M
2017-83.62K
2016-20.99K
Operating Income (USD)
-4M-3M-2M-1M0201620172018201920202021202220232024
NXEN Operating Income (USD) by year
PeriodOperating Income (USD)
2024-155.66K
2023-282.61K
2022-563.15K
2021-2.12M
2020-2.6M
2019-3.93M
2018-1.28M
2017-268.77K
2016-19.73K
EBITDA (USD)
-6M-4M-2M02M201620172018201920202021202220232024
NXEN EBITDA (USD) by year
PeriodEBITDA (USD)
2024-77.71K
20230
2022838
2021-607.3K
2020-742.32K
2019-4.3M
2018-1.28M
201770.03K
2016-3.53K
Cash Flows (USD)
-1M-750K-500K-250K0201620172018201920202021202220232024
NXEN Cash Flows (USD) by year
PeriodCash Flows (USD)
2024-64.36K
2023-81.75K
2022-75.14K
2021-90.75K
2020-147.57K
2019-663.38K
2018-875.34K
2017-258.99K
2016-16.35K
EPS (USD)
-0.1-0.08-0.05-0.03-0201620172018201920202021202220232024
NXEN EPS (USD) by year
PeriodEPS (USD)
2024-0
2023-0.01
2022-0.01
2021-0.03
2020-0.05
2019-0.08
2018-0.03
2017-0.01
2016-0
Expenses (USD)
-1M01M2M3M4MR&DSG&ACapex201620172018201920202021202220232024
NXEN Expenses (USD) by year
PeriodExpenses (USD)
2024155.66K
2023282.61K
2022563.99K
20211.84M
20202.6M
20193.95M
20181.28M
2017384.08K
201619.73K
Cash & Debt (USD)
0250K500K750K1MCashShort Term Debt201620172018201920202021202220232024
NXEN Cash & Debt (USD) by year
PeriodCash & Debt (USD)
20244.18K
202335.15K
2022116.9K
202118.04K
202010.79K
2019146.36K
2018819.74K
2017242.78K
20160
Debt ratios
-0.6-0.4-0.2-00.2201920202021202220232024
NXEN Debt ratios by year
PeriodDebt ratios
2024-0.45
2023-0.18
2022-0.01
20210
2020-0
20190.03
Return on Capital
-40000000%-30000000%-20000000%-10000000%0%10000000%201620172018201920202021202220232024
NXEN Return on Capital by year
PeriodReturn on Capital
202466.19%
2023-32636223.88%
2022532.29%
202113501.28%
202041979.58%
2019-1617.4%
2018-108.4%
2017-14.85%
201630.02%
Shares Outstanding
020M40M60M80M201620172018201920202021202220232024
NXEN Shares Outstanding by year
PeriodShares Outstanding
202464.02M
202364.02M
202255.77M
202153.98M
202053.98M
201953.65M
201843.78M
201724.42M
201622.71M
Book Value Per Share (USD)
-0.0100.010.020.03201620172018201920202021202220232024
NXEN Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
2024-0.01
2023-0
2022-0
2021-0
2020-0
20190
20180.03
20170.02
2016-0
Total Assets (USD)
0500K1M1.5M201620172018201920202021202220232024
NXEN Total Assets (USD) by year
PeriodTotal Assets (USD)
20244.18K
202343.13K
2022124.52K
202125.54K
202022.79K
2019310.67K
20181.27M
2017773.69K
20160
Employee Count
012342018
NXEN Employee Count by year
PeriodEmployee Count
20183
PE Ratio
00000med 0Jun 23Aug 23Sep 23Nov 23Jan 24Mar 24May 24
NXEN PE Ratio by year
PeriodPE Ratio
May 240
May 240
Apr 240
Apr 240
Apr 240
Apr 240
Mar 240
Mar 240
Mar 240
Mar 240
Mar 240
Feb 240
Feb 240
Feb 240
Feb 240
Jan 240
Jan 240
Jan 240
Jan 240
Dec 230
Dec 230
Dec 230
Dec 230
Dec 230
Nov 230
Nov 230
Nov 230
Nov 230
Oct 230
Oct 230
Oct 230
Oct 230
Sep 230
Sep 230
Sep 230
Sep 230
Sep 230
Aug 230
Aug 230
Aug 230
Aug 230
Jul 230
Jul 230
Jul 230
Jul 230
Jun 230
Jun 230
Jun 230
Jun 230
Jun 230
May 230
May 230
Free Cash Flow Yield
-1000%-750%-500%-250%0%med -14.55%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NXEN Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-872.91%
Sep 26-872.91%
Aug 26-872.91%
Aug 26-872.91%
Aug 26-872.91%
Aug 26-872.91%
Jul 26-872.91%
Jul 26-872.91%
Jul 26-872.91%
Jul 26-872.91%
Jul 26-872.91%
Jun 26-872.91%
Jun 26-872.91%
Jun 26-872.91%
Jun 26-872.91%
May 26-872.91%
May 26-872.91%
May 26-872.91%
May 26-872.91%
May 26-872.91%
Apr 26-872.91%
Apr 26-872.91%
Apr 26-872.91%
Apr 26-872.91%
Mar 26-872.91%
Mar 26-872.91%
Mar 26-872.91%
Mar 26-872.91%
Feb 26-872.91%
Feb 26-872.91%
Feb 26-872.91%
Feb 26-872.91%
Jan 26-872.91%
Jan 26-872.91%
Jan 26-872.91%
Jan 26-872.91%
Jan 26-872.91%
Dec 25-872.91%
Dec 25-872.91%
Dec 25-872.91%
Dec 25-872.91%
Nov 25-872.91%
Nov 25-872.91%
Nov 25-872.91%
Nov 25-48.5%
Oct 25-7.27%
Oct 25-7.27%
Oct 25-7.27%
Oct 25-7.27%
Oct 25-7.27%
Sep 25-7.27%
Sep 25-14.55%
Sep 25-7.27%
Sep 25-7.34%
Aug 25-6.71%
Aug 25-87.29%
Aug 25-14.55%
Aug 25-14.55%
Aug 25-14.55%
Jul 25-14.55%
Jul 25-14.55%
Jul 25-14.55%
Jul 25-12.47%
Jun 25-14.55%
Jun 25-9.7%
Jun 25-14.55%
Jun 25-5.82%
May 25-8.73%
May 25-8.73%
May 25-8.73%
May 25-9.85%
May 25-10.16%
Apr 25-10.37%
Apr 25-10.95%
Apr 25-10.95%
Apr 25-7.04%
Mar 25-9.85%
Mar 25-7.04%
Mar 25-7.04%
Mar 25-7.04%
Feb 25-14.07%
Feb 25-14.07%
Feb 25-14.07%
Feb 25-11.45%
Jan 25-13.36%
Jan 25-13.36%
Jan 25-7.29%
Jan 25-7.29%
Jan 25-5.01%
Dec 24-14.32%
Dec 24-13.36%
Dec 24-14.58%
Dec 24-4.22%
Nov 24-5.69%
Nov 24-4.01%
Nov 24-7.73%
Nov 24-7.18%
Nov 24-2.03%
Oct 24-2.14%
Oct 24-2.28%
EV/EBITDA
02000400060008000med 4210.97Mar 22May 22Aug 22Oct 22Dec 22Mar 23May 23
NXEN EV/EBITDA by year
PeriodEV/EBITDA
May 236579.58
May 236502.77
Apr 235734.59
Apr 234966.41
Apr 234966.41
Apr 234966.41
Mar 234966.41
Mar 235542.55
Mar 234582.32
Mar 235504.14
Mar 236410.59
Feb 235619.36
Feb 235872.86
Feb 235135.41
Feb 232448.04
Jan 232814.89
Jan 232753.75
Jan 232714.35
Jan 233429.71
Dec 224098.88
Dec 223528.22
Dec 224160.02
Dec 224173.61
Dec 224248.34
Nov 222760.54
Nov 222760.54
Nov 222760.54
Nov 222673.65
Oct 223066.32
Oct 222820.07
Oct 223202.09
Oct 224696.89
Sep 224463.96
Sep 224307.67
Sep 224128.63
Sep 224379.28
Sep 226062.19
Aug 224164.44
Aug 225471.38
Aug 223734.76
Aug 224504.6
Jul 224558.31
Jul 224486.7
Jul 224916.38
Jul 224021.21
Jul 225281.61
Jun 224486.7
Jun 224934.28
Jun 224665.73
Jun 225346.06
May 225163.45
May 224665.73
May 224486.7
May 2216.77
Apr 2216
Apr 2217.28
Apr 2237.29
Apr 2225.75
Apr 2215.46
Mar 2211.38
Mar 228.84
Mar 2211.91
Mar 2211.91
Feb 2212.65
Feb 2212.78
Feb 2212.88
Price to Book
0200400600med 26.14Sep 19Dec 19Apr 20Jul 20Mar 21Jun 21Oct 21
NXEN Price to Book by year
PeriodPrice to Book
Oct 21209.09
Oct 21188.66
Sep 21237.49
Sep 21225.55
Sep 21220.9
Sep 21203.66
Aug 21212.28
Aug 21218.78
Aug 21185.74
Aug 21185.74
Jul 21214.93
Jul 21185.74
Jul 21201.93
Jul 21225.55
Jul 21344.95
Jun 21185.48
Jun 21265.08
Jun 21289.23
Jun 21265.35
May 21261.24
May 21225.55
May 21264.82
May 21360.34
Apr 21258.35
Apr 21338.79
Apr 21362.86
Apr 21457.98
Apr 21290.99
Mar 21291.23
Mar 21277.37
Mar 21385.17
Mar 21435.38
Feb 21375.78
Feb 21361.68
Feb 21326.46
Sep 2034.18
Sep 2055.26
Sep 2053.87
Sep 2043.58
Aug 2039.81
Aug 2042.7
Aug 2051.22
Aug 2046.15
Jul 2051.28
Jul 2061.22
Jul 2079.76
Jul 2079.19
Jul 2027.75
Jun 2024.01
Jun 2028.37
Jun 2010.54
Jun 205.27
May 209.12
May 2012.68
May 2017.43
May 2013.69
May 2026.04
Apr 2017.62
Apr 2018.05
Apr 2015.88
Apr 2016.11
Mar 2013.08
Mar 2020.19
Mar 2015.56
Mar 2013.04
Feb 2014.72
Feb 2021.03
Feb 2022.71
Feb 2011.86
Jan 2014.24
Jan 2011
Jan 2018.69
Jan 2019.28
Jan 2019.28
Dec 1914.44
Dec 1913.75
Dec 1910.27
Dec 1921.68
Nov 1910.82
Nov 1917.11
Nov 1926.24
Nov 1918.08
Nov 1916.1
Oct 1910.09
Oct 1918.1
Oct 1915.57
Oct 1918.46
Sep 196.53
Sep 196.53
Sep 196.63
Sep 195.74
Aug 194.7
Aug 197.18
Aug 197.18
Aug 197.18
Aug 197.18
Jul 197.18
Jul 197.18
Jul 196.82
Jul 196.46
Nexien BioPharma, Inc.
NXEN
Stockpicker

Video analysis: NXEN

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.